Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-06-09
1990-11-06
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514459, 514824, 549292, A61K 3136, C02D30930
Patent
active
049686933
ABSTRACT:
Compounds of formula (I) and (II): ##STR1## are HMG-CoA reductase inhibitors.
REFERENCES:
patent: 4361515 (1982-11-01), Terahara et al.
patent: 4517373 (1985-05-01), Terahara et al.
patent: 4582915 (1986-04-01), Sleteinger et al.
patent: 4833258 (1989-05-01), Smith et al.
patent: 4857522 (1989-08-01), Di Pietro et al.
Joshua Henry
Lee Ta J.
Schwartz Michael S.
Stokker Gerald E.
Wilson Kenneth E.
DiPrima Joseph F.
Merck & Co. , Inc.
Raymond Richard L.
Russell Mark W.
Winokur Melvin
LandOfFree
3-keto HMG-COA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-keto HMG-COA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-keto HMG-COA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1307072